Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eylea
Eylea
Innovent's anti-VEGF drug matches Eylea in phase 2 eye disease trial
Fierce Biotech
Tue, 03/19/24 - 11:21 am
Innovent
Regeneron
Bayer
anti-VEGF
neovascular age-related macular degeneration
IBI302
Eylea
US appeals court revives Regeneron's antitrust lawsuit against Novartis
Yahoo/Reuters
Mon, 03/18/24 - 05:09 pm
Novartis
Regeneron
legal
Eylea
Lucentis
antitrust
4DMT gene therapy cuts need for Eylea in wet AMD trial
Pharmaphorum
Mon, 02/5/24 - 10:09 am
4D Molecular Therapeutics
wet age-related macular degeneration
clinical trials
gene therapy
Eylea
13 Therapies Make Clarivate’s 2024 Drugs to Watch List
BioSpace
Wed, 01/10/24 - 06:30 pm
Clarivate
Eylea
Tarpeyo/Kinpeygo
Dato-DXd
Altuviiio
RPL554
exa-cel
lovo-cel
LY-3074828
Akeega
Abrysvo
Talvey
Arexvy
IMAB362
JPM24, Day 1: Regeneron's Eylea misses analyst estimates; Moderna touts $6.7B in '23 sales
Fierce Pharma
Mon, 01/8/24 - 11:45 am
JPMHC 2024
Regeneron
Eylea
Eylea HD
Moderna Therapeutics
Regeneron Gains After Eye-Drug Patent Victory Over Viatris
Yahoo/Bloomberg
Sun, 12/31/23 - 11:46 am
Regeneron
Eylea
Viatris
patents
legal
EyePoint Pharma Stock Surges on Phase II Wet AMD-Therapy Results
BioSpace
Mon, 12/4/23 - 06:12 pm
Eyepoint
clinical trials
wet age-related macular degeneration
Eylea
EYP-1901
European regulator endorses high-dose version of Bayer eye drug Eylea
Reuters
Fri, 11/10/23 - 10:09 am
Bayer
EMA
Eylea
Roche
Regeneron touts launch of high-dose Eylea in battle with Roche's Vabysmo
Fierce Pharma
Thu, 11/2/23 - 11:48 am
Regeneron
Eylea
Roche
Vabysmo
Could This Biosimilar Drug Be Novartis' Next Blockbuster?
Motley Fool
Tue, 09/5/23 - 08:39 pm
Novartis
biosimilars
Eylea
Regeneron Expands Eylea’s Label with High-Dose Approval
BioSpace
Mon, 08/21/23 - 10:44 am
Regeneron
Eylea
FDA
Sandoz plans to enter the Eylea biosimilar race
Clinical Trials Arena
Tue, 08/15/23 - 10:03 am
Sandoz
generics
biosimilars
Eylea
Novartis
wet age-related macular degeneration
Regeneron's high-dose Eylea shows staying power as company awaits FDA decision
Fierce Pharma
Thu, 08/10/23 - 09:49 pm
Regeneron
Eylea
age-related macular degeneration
FDA
Regeneron expects FDA decision on higher-dose Eylea this year
Reuters
Thu, 08/3/23 - 06:40 pm
Regeneron
Eylea
FDA
Is Regeneron's Stock in Trouble After This FDA Rejection?
Motley Fool
Thu, 07/6/23 - 10:15 am
Regeneron
Eylea
FDA
Regeneron's high-dose Eylea hit with surprise FDA rejection over manufacturing hiccups
Fierce Pharma
Tue, 06/27/23 - 10:24 pm
Regeneron
Eylea
FDA
Roche’s new eye drug pressures Eylea with strong launch
BioPharma Dive
Wed, 04/26/23 - 05:44 pm
Roche
Vabysmo
Eylea
earnings
Regeneron
5 FDA decisions to watch in the second quarter
BioPharma Dive
Mon, 04/3/23 - 11:06 pm
FDA
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Biogen
tofersen
ALS
Seres Therapeutics
C. difficile
Pfizer
GSK
vaccines
RSV
Regeneron
Eylea
Bayer grapples with Eylea sales slowdown, sees trend continuing in 2023
Fierce Pharma
Tue, 02/28/23 - 10:41 pm
Bayer
earnings
Eylea
In showdown with Roche, Regeneron gears up for potential Eylea expansion amid Covid decline
Endpoints
Mon, 02/6/23 - 10:35 am
Regeneron
earnings
Eylea
Pages
1
2
3
4
5
6
7
8
9
next ›
last »